A Phase I, Single Centre, Randomized, Open-Label, Three-Period Crossover Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA With a Single 4 g Dose of AZD0585 in Healthy Male Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 17 May 2016
At a glance
- Drugs Omega-3 carboxylic acids (Primary)
- Indications Unspecified
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors AstraZeneca
- 26 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Apr 2015 Planned End Date changed from 1 May 2015 to 1 Apr 2015, as reported by ClinicalTrials.gov.
- 07 Apr 2015 Planned primary completion date changed from 1 May 2015 to 1 Apr 2015, as reported by ClinicalTrials.gov.